IDEAYA Biosciences Financials - Benzinga

IDEAYA Biosciences Inc

IDYANASDAQ

Trade with Public

Trade with Public

$37.02

0.782.15%

At close: Aug 7, 5:00 PM EST

$37.02

N/A

After Hours: 4:00 PM EST

Earnings: Q2 2026 Earnings were released on Tue Aug 4th, before the market open

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

IDEAYA Biosciences Financials

IDEAYA Biosciences (IDYA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
IDEAYA Biosciences Q2 EPS $(1.22) Misses $(1.09) Estimate, Sales $8.857M Beat $5.015M Estimate

IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(1.22) per share which missed the analyst consensus estimate of $(1.09) by 11.93 percent. This is a 38.64 percent decrease over losses of $(0.88) per share

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
IDEAYA Biosciences Q1 EPS $(1.11) Misses $(0.98) Estimate, Sales $6.560M Beat $5.008M Estimate

IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(1.11) per share which missed the analyst consensus estimate of $(0.98) by 13.27 percent. This is a 35.37 percent decrease over losses of $(0.82) per share

Benzinga Newsdesk

Stock Market Today: Dow Futures Fall As Trump Announces Strait Of Hormuz Blockade—Goldman Sachs, Fastenal In Focus (UPDATED)

Editor’s note: The future prices of benchmark tracking ETFs and pre-market prices of stocks have been updated. U.S. stock futures declined on Monday following Friday's mixed close. Futures of major benchmark indices were lower after President Donald Trump announced a blockade of the Strait of Hormuz.

Benzinga Neuro

Earnings Scheduled For February 17, 2026

Benzinga Insights

IDEAYA Biosciences Q4 Earnings Report: What Investors Need to Know

Benzinga Insights